NKTR
Nektar Therapeutics · Healthcare
President and CEO Howard W Robin sold $31K of Nektar Therapeutics
Sold$30,879
$73.00Price
423Shares
−1%Stake
What NKTR did after the filing
- The stock from Fri, Feb 20 close, $73.73
- +1.3%
- S&P 500, same days
- −4.4%
Measured over 30 trading days, to the Apr 6 close.
Traded Wed, Feb 18. Filed Fri, Feb 20, 2:10 PM ET, during the session. Returns use the Feb 20 close and the Apr 6 close. Not investment advice.